Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 37

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 1A
Chunk 37
---
ursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Zevra Therapeutics, Inc.Date:August 12, 2025By:/s/ Neil F. McFarlaneNeil F. McFarlanePresident and Chief Executive Officer(Principal Executive Officer)Date:August 12, 2025By:/s/ R. LaDuane CliftonR. LaDuane Clifton, MBA, CPAChief Financial Officer and Treasurer(Principal Financial Officer)

52